Click for best price
AntiMigraine Drugs Market Size, Share 2022
Market Analysis and Insights: Global AntiMigraine Drugs Market
The global AntiMigraine Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global AntiMigraine Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global AntiMigraine Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global AntiMigraine Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global AntiMigraine Drugs market.
Global AntiMigraine Drugs Scope and Market Size
Anti-Migraine Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Triptans
Ergots
Others
Segment by Application
Women
Men
By Company
Eli Lilly
Abbott
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes AntiMigraine Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of AntiMigraine Drugs, with price, sales, revenue, and global market share of AntiMigraine Drugs from 2019 to 2022.
Chapter 3, the AntiMigraine Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AntiMigraine Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the AntiMigraine Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of AntiMigraine Drugs.
Chapter 13, 14, and 15, to describe AntiMigraine Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 AntiMigraine Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Anti-Migraine Drugs Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Anti-Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Triptans
1.2.3 Ergots
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anti-Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Migraine Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Migraine Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Migraine Drugs Sales by Region
2.4.1 Global Anti-Migraine Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Migraine Drugs by Region (2023-2028)
2.5 Global Anti-Migraine Drugs Revenue by Region
2.5.1 Global Anti-Migraine Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-Migraine Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Migraine Drugs Sales by Manufacturers
3.1.1 Global Top Anti-Migraine Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Migraine Drugs in 2021
3.2 Global Anti-Migraine Drugs Revenue by Manufacturers
3.2.1 Global Anti-Migraine Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Migraine Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Migraine Drugs Revenue in 2021
3.3 Global Anti-Migraine Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Migraine Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Migraine Drugs Sales by Type
4.1.1 Global Anti-Migraine Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Migraine Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-Migraine Drugs Revenue by Type
4.2.1 Global Anti-Migraine Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Migraine Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Migraine Drugs Price by Type
4.3.1 Global Anti-Migraine Drugs Price by Type (2017-2022)
4.3.2 Global Anti-Migraine Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Migraine Drugs Sales by Application
5.1.1 Global Anti-Migraine Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Migraine Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti-Migraine Drugs Revenue by Application
5.2.1 Global Anti-Migraine Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Migraine Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Migraine Drugs Price by Application
5.3.1 Global Anti-Migraine Drugs Price by Application (2017-2022)
5.3.2 Global Anti-Migraine Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Migraine Drugs Market Size by Type
6.1.1 North America Anti-Migraine Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-Migraine Drugs Revenue by Type (2017-2028)
6.2 North America Anti-Migraine Drugs Market Size by Application
6.2.1 North America Anti-Migraine Drugs Sales by Application (2017-2028)
6.2.2 North America Anti-Migraine Drugs Revenue by Application (2017-2028)
6.3 North America Anti-Migraine Drugs Market Size by Country
6.3.1 North America Anti-Migraine Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-Migraine Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Migraine Drugs Market Size by Type
7.1.1 Europe Anti-Migraine Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-Migraine Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-Migraine Drugs Market Size by Application
7.2.1 Europe Anti-Migraine Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti-Migraine Drugs Revenue by Application (2017-2028)
7.3 Europe Anti-Migraine Drugs Market Size by Country
7.3.1 Europe Anti-Migraine Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-Migraine Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Migraine Drugs Market Size by Type
8.1.1 Asia Pacific Anti-Migraine Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Migraine Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Migraine Drugs Market Size by Application
8.2.1 Asia Pacific Anti-Migraine Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Migraine Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Migraine Drugs Market Size by Region
8.3.1 Asia Pacific Anti-Migraine Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Migraine Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-Migraine Drugs Market Size by Type
9.1.1 Latin America Anti-Migraine Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-Migraine Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-Migraine Drugs Market Size by Application
9.2.1 Latin America Anti-Migraine Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti-Migraine Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti-Migraine Drugs Market Size by Country
9.3.1 Latin America Anti-Migraine Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-Migraine Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Migraine Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-Migraine Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Migraine Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Migraine Drugs Market Size by Application
10.2.1 Middle East and Africa Anti-Migraine Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Migraine Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Migraine Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-Migraine Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Migraine Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Eli Lilly Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Overview
11.3.3 Eisai Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eisai Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eisai Recent Developments
11.4 Allergan
11.4.1 Allergan Corporation Information
11.4.2 Allergan Overview
11.4.3 Allergan Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Allergan Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Allergan Recent Developments
11.5 Endo
11.5.1 Endo Corporation Information
11.5.2 Endo Overview
11.5.3 Endo Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Endo Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Endo Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Overview
11.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Impax Laboratories Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Impax Laboratories Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AstraZeneca Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Overview
11.10.3 Bayer Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bayer Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Corporation Information
11.11.2 Johnson & Johnson Overview
11.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Johnson & Johnson Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Johnson & Johnson Recent Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Overview
11.12.3 Merck Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Merck Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck Recent Developments
11.13 Teva
11.13.1 Teva Corporation Information
11.13.2 Teva Overview
11.13.3 Teva Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Teva Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Teva Recent Developments
11.14 Amgen
11.14.1 Amgen Corporation Information
11.14.2 Amgen Overview
11.14.3 Amgen Anti-Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Amgen Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Migraine Drugs Industry Chain Analysis
12.2 Anti-Migraine Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Migraine Drugs Production Mode & Process
12.4 Anti-Migraine Drugs Sales and Marketing
12.4.1 Anti-Migraine Drugs Sales Channels
12.4.2 Anti-Migraine Drugs Distributors
12.5 Anti-Migraine Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Migraine Drugs Industry Trends
13.2 Anti-Migraine Drugs Market Drivers
13.3 Anti-Migraine Drugs Market Challenges
13.4 Anti-Migraine Drugs Market Restraints
14 Key Findings in The Global Anti-Migraine Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Anti-Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Triptans
Table 3. Major Manufacturers of Ergots
Table 4. Major Manufacturers of Others
Table 5. Global Anti-Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anti-Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Anti-Migraine Drugs Sales by Region (2017-2022) & (K Units)
Table 8. Global Anti-Migraine Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Anti-Migraine Drugs Sales by Region (2023-2028) & (K Units)
Table 10. Global Anti-Migraine Drugs Sales Market Share by Region (2023-2028)
Table 11. Global Anti-Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Anti-Migraine Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global Anti-Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Anti-Migraine Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global Anti-Migraine Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Anti-Migraine Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global Anti-Migraine Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Anti-Migraine Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. Anti-Migraine Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 20. Global Anti-Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2021)
Table 22. Anti-Migraine Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Anti-Migraine Drugs Product Offered
Table 24. Date of Manufacturers Enter into Anti-Migraine Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 27. Global Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 28. Global Anti-Migraine Drugs Sales Share by Type (2017-2022)
Table 29. Global Anti-Migraine Drugs Sales Share by Type (2023-2028)
Table 30. Global Anti-Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Anti-Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Anti-Migraine Drugs Revenue Share by Type (2017-2022)
Table 33. Global Anti-Migraine Drugs Revenue Share by Type (2023-2028)
Table 34. Anti-Migraine Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 35. Global Anti-Migraine Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 36. Global Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Anti-Migraine Drugs Sales Share by Application (2017-2022)
Table 39. Global Anti-Migraine Drugs Sales Share by Application (2023-2028)
Table 40. Global Anti-Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Anti-Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Anti-Migraine Drugs Revenue Share by Application (2017-2022)
Table 43. Global Anti-Migraine Drugs Revenue Share by Application (2023-2028)
Table 44. Anti-Migraine Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 45. Global Anti-Migraine Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 46. North America Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Anti-Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Anti-Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 51. North America Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 52. North America Anti-Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Anti-Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
Table 55. North America Anti-Migraine Drugs Sales by Country (2023-2028) & (K Units)
Table 56. North America Anti-Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Anti-Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Anti-Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Anti-Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 63. Europe Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 64. Europe Anti-Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Anti-Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Anti-Migraine Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Anti-Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Anti-Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Anti-Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Anti-Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Anti-Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Anti-Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Anti-Migraine Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Anti-Migraine Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Anti-Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Anti-Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Anti-Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Anti-Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Anti-Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Anti-Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Anti-Migraine Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Anti-Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Anti-Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Anti-Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Anti-Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Anti-Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Anti-Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Anti-Migraine Drugs Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Eli Lilly Corporation Information
Table 107. Eli Lilly Description and Major Businesses
Table 108. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 109. Eli Lilly Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Eli Lilly Recent Developments
Table 111. Abbott Corporation Information
Table 112. Abbott Description and Major Businesses
Table 113. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 114. Abbott Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Abbott Recent Developments
Table 116. Eisai Corporation Information
Table 117. Eisai Description and Major Businesses
Table 118. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 119. Eisai Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Eisai Recent Developments
Table 121. Allergan Corporation Information
Table 122. Allergan Description and Major Businesses
Table 123. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 124. Allergan Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Allergan Recent Developments
Table 126. Endo Corporation Information
Table 127. Endo Description and Major Businesses
Table 128. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 129. Endo Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Endo Recent Developments
Table 131. GlaxoSmithKline Corporation Information
Table 132. GlaxoSmithKline Description and Major Businesses
Table 133. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 134. GlaxoSmithKline Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. GlaxoSmithKline Recent Developments
Table 136. Impax Laboratories Corporation Information
Table 137. Impax Laboratories Description and Major Businesses
Table 138. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Impax Laboratories Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Impax Laboratories Recent Developments
Table 141. Pfizer Corporation Information
Table 142. Pfizer Description and Major Businesses
Table 143. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 144. Pfizer Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Pfizer Recent Developments
Table 146. AstraZeneca Corporation Information
Table 147. AstraZeneca Description and Major Businesses
Table 148. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 149. AstraZeneca Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. AstraZeneca Recent Developments
Table 151. Bayer Corporation Information
Table 152. Bayer Description and Major Businesses
Table 153. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 154. Bayer Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Bayer Recent Developments
Table 156. Johnson & Johnson Corporation Information
Table 157. Johnson & Johnson Description and Major Businesses
Table 158. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 159. Johnson & Johnson Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Johnson & Johnson Recent Developments
Table 161. Merck Corporation Information
Table 162. Merck Description and Major Businesses
Table 163. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 164. Merck Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Merck Recent Developments
Table 166. Teva Corporation Information
Table 167. Teva Description and Major Businesses
Table 168. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 169. Teva Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Teva Recent Developments
Table 171. Amgen Corporation Information
Table 172. Amgen Description and Major Businesses
Table 173. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 174. Amgen Anti-Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Amgen Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Anti-Migraine Drugs Distributors List
Table 179. Anti-Migraine Drugs Customers List
Table 180. Anti-Migraine Drugs Market Trends
Table 181. Anti-Migraine Drugs Market Drivers
Table 182. Anti-Migraine Drugs Market Challenges
Table 183. Anti-Migraine Drugs Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Migraine Drugs Product Picture
Figure 3. Global Anti-Migraine Drugs Market Share by Type in 2021 & 2028
Figure 3. Triptans Product Picture
Figure 4. Ergots Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Migraine Drugs Market Share by Application in 2021 & 2028
Figure 7. Women
Figure 8. Men
Figure 9. Anti-Migraine Drugs Report Years Considered
Figure 10. Global Anti-Migraine Drugs Sales 2017-2028 (K Units)
Figure 11. Global Anti-Migraine Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Anti-Migraine Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Anti-Migraine Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Anti-Migraine Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Anti-Migraine Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Anti-Migraine Drugs Sales YoY (2017-2028) & (K Units)
Figure 17. North America Anti-Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Anti-Migraine Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Anti-Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Anti-Migraine Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Anti-Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Anti-Migraine Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Anti-Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Anti-Migraine Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Anti-Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Anti-Migraine Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Anti-Migraine Drugs in the World: Market Share by Anti-Migraine Drugs Revenue in 2021
Figure 28. Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Anti-Migraine Drugs Sales Share by Country (2017-2028)
Figure 38. North America Anti-Migraine Drugs Revenue Share by Country (2017-2028)
Figure 39. U.S. Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 45. Europe Anti-Migraine Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Anti-Migraine Drugs Revenue Share by Country (2017-2028)
Figure 47. Germany Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. France Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Anti-Migraine Drugs Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Anti-Migraine Drugs Revenue Share by Region (2017-2028)
Figure 58. China Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. India Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 69. Latin America Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 71. Latin America Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Anti-Migraine Drugs Sales Share by Country (2017-2028)
Figure 73. Latin America Anti-Migraine Drugs Revenue Share by Country (2017-2028)
Figure 74. Mexico Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Anti-Migraine Drugs Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Anti-Migraine Drugs Revenue Share by Country (2017-2028)
Figure 83. Turkey Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Anti-Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Anti-Migraine Drugs Value Chain
Figure 87. Anti-Migraine Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
